An Absolutely Stacked Week of Litigator of the Week Runners-Up and Shout Outs
Latham litigation team recognized for successful appeal to the 11th Circuit on behalf of Catalyst in dispute with FDA.
Leading companies and global market leaders in the medical device, pharmaceutical, biotechnology, cosmetic, tobacco, food, and dietary supplement industries need to know what to expect when interacting with the Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), and Department of Health and Human Services (HHS), including how to:
When serving clients on these and other difficult or cutting-edge matters involving the FDA, DEA, HHS, FTC, and Congress, Latham’s FDA Regulatory has the institutional experience and insight to produce successful outcomes; whether by placing the right call or, if necessary, litigating through trial. In Washington, the team includes lawyers who previously held the following government positions:
Latham litigation team recognized for successful appeal to the 11th Circuit on behalf of Catalyst in dispute with FDA.
Market-leading advice in key litigation, regulatory and transactional areas recognized.
For serving as lead counsel in a dispute that prompted a rare formal withdrawal of an FDA warning letter, John Manthei, co-chair and Washington, D.C. chair of the Healthcare & Life Sciences Practice, is honored as a Life Sciences MVP.